Dr Ahmed Jamsheed Mohamed WHO South East Asia Regional Office 9-11 February 2015.

Slides:



Advertisements
Similar presentations
New Challenges in M&E Lets go. Scaling Up Monitoring & Evaluation Strategic Information PROGRAM GUIDANCE RESULT NEEDS OPPORTUNITIES Resources New directions.
Advertisements

Neglected Tropical Diseases and Malaria: The need for mapping.
Module 2 Eligibility for a TAS TAS Global Programme to Eliminate Lymphatic Filariasis (GPELF) Training in monitoring and epidemiological assessment of.
Training in monitoring and epidemiological assessment of mass drug administration for eliminating lymphatic filariasis Module 1 Background.
Module 6 After the survey TAS Global Programme to Eliminate Lymphatic Filariasis (GPELF) Training in monitoring and epidemiological assessment of mass.
Strategies for Working with Countries – Regional and Sub-Regional Perspective and Experiences Essential Drugs and Medicines Policy WHO South-East Asia.
Kabatereine Narcis NEED FOR IMPROVING IN-COUNTRY CAPACITY FOR BETTER DELIVERY. AFRICAN SCI CAPACITY BUILDING ADVISOR BASED IN UGANDA.
100 years of living science Date Location of Event Integration of NTD Control How to promote efficiency Dr Anna Phillips 27 th June 2014.
PROGRESS REPORT: The National STH Programme in BHUTAN Mr. Sangay Thinley 2014 RPRG Meeting Jakarta, Indonesia 23 – 24 Sept
Professor Alan Fenwick OBE SCI Imperial College London Schistosomiasis and STH control and elimination ICOSA (LF, Oncho and trachoma)
Regional Situation on ICD Implementation and Related Activities in the South East Asia Region of WHO Jyotsna Chikersal RA-HST, WHO-SEARO WHO-FIC APN Meeting,
Progress report: the National LF and STH programme in MYANMAR Dr. Ni Ni Aye, Program Manager (ELF) LF and STH program Mangers Meeting,Jakarta (23-24 sept,2014)
Module 3 Evaluation unit
Regional initiative to sustain country achievement SEAR Krongthong Thimasarn Regional Adviser, Malaria World Health Organization Regional Office for South-
MINISTRY OF COMMUNITY DEVELOPMENT MOTHER AND CHILD HEALTH MRS. ELIKA KAMIJI CHIEF EPI OFFICER IMPLEMENTATION OF GAPPD: ZAMBIAN EXPERIENCE Global Immunization.
Eliminating Lymphatic Filariasis in the Americas A Winnable Battle Center for Global Health Division of Parasitic Diseases and Malaria.
The Work of WHO in the South-East Asia Region The Work of WHO in the South-East Asia Region Biennial Report of the Regional Director 1 January
Months of implementation period 26 th September – Closure of project Focus – India/Indonesia/Sri Lanka/Maldives Building.
NTDs and eye health: lessons learnt and opportunities for collaboration Adrian D Hopkins Director: Mectizan Donation Program Task Force for Global Health.
Post-MDA surveillance ( including xeno-monitoring) Krishnamoorthy K. Vector Control Research Centre Pondicherry India.
1 |1 | Key problems Neglected Tropical Diseases Hidden and silent : Key problems Complacency, lack of information and commitment Complacency, lack of information.
GETTING READY FOR DUAL EMTCT VALIDATION IN THE AMERICAS Adele Schwartz Benzaken.
Progress towards Sustainable Measles Mortality Reduction South-East Asia Region Jayantha Liyanage Medical Officer- EPI Immunization and Vaccine Development.
100 years of living science Date Location of Event Annual Board Meeting 27 th June 2013 Donor supported programmes Dr Giuseppina Ortu SCI Programme Manager.
INTEGRATED CONTROL OF NEGLECTED TROPICAL DISEASES (NTDs) IN UGANDA 1 Dr. Ambrose Onapa NTDCP/RTI (ENVISION)
School-based deworming Challenges Collaborations Commitment.
PADI Action Agenda for China(draft) History of Poverty Reduction in China History of Monitoring & Evaluation in Poverty Reduction Objectives.
Multi-Year Plans Strengthening immunization systems and introduction of hepatitis B vaccine in Central Europe and the Newly Independent States St. Petersburg,
Module 7 Verification of elmination TAS Global Programme to Eliminate Lymphatic Filariasis (GPELF) Training in monitoring and epidemiological assessment.
Palestine Bahrain Global Measles and Rubella Management Meeting Boubker Naouri March, 2011 Geneva, WHO HQ.
1 1 Bose: SEAR Highlights and Priorities Global Measles & Rubella Management Meeting Geneva, March 2011 Accelerated Measles Control: Highlights and.
Western Pacific Region 1 Bi-regional Malaria Surveillance and M&E Workshop, Phnom Penh, 6–7 May 2010 Bi-regional Workshop on Malaria Surveillance and Monitoring.
Looking Forward the Post-2015 Sustainable Development Goals (SDGs) UNSD-DFID Project on National Development Indicators: Country Director's Meeting, New.
Global burden of LF Around 1.4 billion people in 73 countries at risk Over 120 million infected About 40 million disfigured and incapacitated.
6th NTD STAG Global Working Group Meeting on M&E of Preventive Chemotherapy 9-11 February 2015 Salle B, Geneva NTD PCT M&E Western Pacific Region WPRO/MVP/NTD:
Recent Epidemiologic Situations of TB in Myanmar -Preliminary Review of Data from routine TB surveillance focusing on Case Finding- 9 May 2014, Nay Pyi.
SCI’s contribution to the global effort to control and eliminate schistosomiasis Dr Wendy Harrison 26 th June 2014.
Monitoring and Evaluation issues related to Preventive Chemotherapy (LF and STH) Dr. S. K. Jain Joint Director & Head Department of Parasitic Diseases.
Progress Report: National LF and STH Programme in Nepal
WHO/OMS Improving and increasing investments in the health outcomes of the poor Macroeconomics and Health in context Dr. Sergio Spinaci, WHO Senegal, February.
Progress report: the national LF and STH programme in Thailand By Sunsanee Rojanapanus, Dr. Thitima Wongsaroj 2014 RPRG Meeting WHO Region.
Working to overcome the global impact of neglected tropical diseases Regional Lymphatic Filariasis Elimination Program Managers’ Meeting Southeast Asia.
Status of EPI In Guinea DR. Mariama BAH Child Survival Advisor USAID/Guinea June 13, 2002.
Human resources for malaria elimination Deyer Gopinath GMS Malaria Elimination Course 10 – 21 August 2015, Chiang Mai, Thailand.
Indicators in Malaria Program Phases By Bayo S Fatunmbi [Technical Officer, Monitoring & Evaluation] ERAR-GMS, WHO Cambodia & Dr. Michael Lynch Epidemiologist.
Indicators in Malaria Program Phases By Bayo S Fatunmbi [Technical Officer, Monitoring & Evaluation] ERAR-GMS, WHO Cambodia.
Transport against AIDS Joint Initiative to Mitigate HIV/AIDS in Infrastructure Sectors: Update from World Bank Transport sector Julie Babinard Transport.
National Influenza Centres in SEA Region Dr Rajesh Bhatia / Dr Oommen John WHO Regional Office for South-East Asia New Delhi 5 th Meeting of NIC in Western.
ACTED AME Appraisal, Monitoring and Evaluation. Summary 1/ ACTED AME department 2/ AME Responsibilities 3/ AME throughout project cycle 4/ Involvement.
Mohamed Faisal 2014 RPRG Meeting WHO Region.  Geography and Population ◦ Total population: 371,507 (Census 2006) ◦ Ecological zones – next slide  Political.
Working to overcome the global impact of neglected tropical diseases Documenting the achievement of elimination as a public health problem GPELF dossier.
IMPROVING ACCESS TO TREATMENT OF THE NTDS – CHALLENGES AND MEASURES Dr. Sultani Matendechero Head, Kenya National NTD Programme.
Joint application package (JAP)  Joint Application Package (JAP) was rolled out as an an integrated planning tool, rather than just an application form.
Regional Workshop on Viral Hepatitis – WHO SEAR
M & E of Neglected Infectious Diseases/PCT - overview Region of the Americas Regional Program for Neglected Infectious Diseases Pan American Health Organization/World.
USAID Neglected Tropical Diseases Program. 2 WHO 17 Neglected Tropical Diseases (NTDs) by Strategic Interventions London Declaration 10 NTDs USAID 5 NTDs.
Accelerating Literacy Actions Chu Shiu Kee 31 August 2011.
Study of Trends in South Asia:
World Health Organization
Dr. Upendo John Mwingira NTD programme manager
World Health Organization
Presented by Jianping YAN UNDP/ BCPR/ GRIP On behalf of
Key Affected Populations
SARI Information System & Data Dashboard Suriname
APPMG December 17, 2008 Presented by Dr. John P. Rumunu (MPH, MB.BS)
Where we could be by 2015 and how to get there
ERASMUS+ Capacity-building in Higher Education
Training Workshop – Module 3
Key Affected Populations
RTI International Daniel A. Cohn Sr Technical Advisor
Presentation transcript:

Dr Ahmed Jamsheed Mohamed WHO South East Asia Regional Office 9-11 February 2015

Endemicity of NTDs amenable to PCT NTDEndemic countriesNo. of countries requiring PC LF9/116/9 STH118/11 SCH1/111 TRA3/113

Integrated NTD Plans Countries with integrated NTD plans: 4/11 Coun try Diseases coveredSource of Funding BANLF, STH, VL (Draft) Gvt + donour (USAID, CNTD, CWW, J&J) BHUPlan to develop in 2015 Gvt INOLF, STH, SCH, yaws & leprosy Gvt + donour (USAID, RTI, GNNTD) MMRLF, STH and Trachoma Gvt + donour (GNNTD, JICA) NEPLF, STH and Trachoma Gvt + donour (USAID) TLSLF, STH and yaws Gvt + donour (GNNTD, Uni of Sydney & Rotary Club)

Regional progress: Feb 2015 Note: IUs requiring MDA might change based on the ongoing survey in BAN and INO Data on IUs eligible for TAS is incomplete

Regional updates Mapping completed by2009. However, BAN and INO decided to resurvey some of the districts BAN18/19 districts passed TAS Resurveying: 13/15 completed MDA in 2015: 1 district IND30/255 districts passed TAS TAS going on in 34 districts TAS plan for : 81 districts MDA 2015: 164 districts INO45/233 districts passed TAS TAS plan for 2015: 26 districts Resurveying: 107 districts (ongoing) MDA in 2015: planned for 158 districts MMR5/45 districts passed TAS TAS plan for 2015: 12 districts MDA not initiated: 7 districts NEP20/61 districts passed TAS TAS plan for 2015: 11 districts TLSPlan to restart MDA in 4 districts: Q3/Q4, 2015

Geographical coverage (LF) Note: Maldives, Sri Lanka & Thailand under post MDA surveillance

Programme coverage (LF)

National coverage (LF)

Number of people treated (LF) 2014 MDA India: completed MDA in 45/136 districts. Rest of the districts expected to be complete by early Q2 in 2015 Indonesia: data (93 districts) not available

Impact assessment

STH coverage 2013: PreSAC

STH coverage 2013: SAC

Schistosomiasis coverage 2014: data may be incomplete

Recent publication Elimination of Lymphatic Filariasis-Current status and way ahead (2014); P.K.Srivastava et al Journal of Communicable Diseases; 2(46) Elimination of Lymphatic Filariasis in Goa: First Successful Transmission Assessment Survey in India (2014); P.K.Srivastava et al Journal of Communicable Diseases; 2(46) 7-16 A Tool for Monitoring Epidemiological Impact of MDA in the Elimination of Lymphatic Filariasis-An Indian Experience (2014); P.K.Srivastava et al Journal of Communicable Diseases; 2(46): 1-6 Gunawardena et al, Integrated School-Based Surveillance for Soil-Transmitted Helminth Infections and Lymphatic Filariasis in Gampaha District, Sri Lanka; Am. J. Trop. Med. Hyg., 90(4), pp. 661–666

Surveillance LF: sentinel and spot checks, TAS, Post MDA surveillance, line listing of lympheodema and hydrocele cases, using HIMS for operated hydrocele cases STH: follow-up stool survey done in BAN TRA: population based survey in NEP Integrated STH and LF surveillance in Sri Lanka

PCT data management WHO standardized tools (JRSM, JRF, AWP) are used by all countries Indonesia has started using integrated NTD database Efficiency and data flow is good in most of the countries but needs improvement in larger countries No regional database Data quality needs improvement in some countries India has taken measures on strengthening data management and M&E: a consultant and 6 additional staff at central level and 17 at state level has been recruited

Programme evaluation in 2014 India JMM of vector-borne diseases Independent appraisal of LF programme through the Indian Council of Medial Research (VCRC) o 12 districts from six states were selected Indonesia National programme evaluation meeting In-depth review of 27 districts with various coverage and performance issues (as per RPRG recommendation) Participated by National Taskforce on Filariasis, WHO (HQ, RO & WCO), RTI along with central and district programme staff

Challenges and needs Inadequate funds Low priority and resource allocation in decentralized settings Weak procurement and supply chain management High cost of TAS and difficulty in getting diagnostics HR constraints Strengthening M&E Poor urban coverage Tackling Hot Spots Expanding coverage and intensifying morbidity management MDA surveillance and sustaining achievement Surveillance in migrant population

Thank You